Immunospecific Regression of Methylcholanthrene Fibrosarcoma Using Neuraminidase. 3. Synergistic Effect of BCG and Neuraminidase Treated Tumor Cells

Overview

Journal Ann Surg

Specialty General Surgery

Date 1972 Aug 1

PMID 4562008

Citations 2

Authors

R L Simmons

A Rios

Affiliations

Soon will be listed here.

Citing Articles

Antitumor immune response following injection of neuraminidase-treated sarcoma cells.

Faraci R, Marrone J, KETCHAM A Ann Surg. 1975; 181(3):359-62.

PMID: 1130852 PMC: 1343861. DOI: 10.1097/00000658-197503000-00018.

Immunology of bronchial carcinoma.

Evans D Thorax. 1976; 31(5):493-506.

PMID: 793085 PMC: 470466. DOI: 10.1136/thx.31.5.493.

References

WEISS L, Mayhew E, Ulrich K . The effect of neuraminidase on the phagocytic process in human monocytes. Lab Invest. 1966; 15(8):1304-9. View

Bagshawe K, CURRIE G . Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase. Nature. 1968; 218(5148):1254-5. DOI: 10.1038/2181254a0. View

Lee A . Effect of neuraminidase on the phagocytosis of heterologous red cells by mouse peritoneal macrophages. Proc Soc Exp Biol Med. 1968; 128(3):891-4. DOI: 10.3181/00379727-128-33150. View

CURRIE G, Bagshawe K . The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour. Br J Cancer. 1968; 22(4):843-53. PMC: 2008363. DOI: 10.1038/bjc.1968.99. View

Woodruff J, GESNER B . The effect of neuraminidase on the fate of transfused lymphocytes. J Exp Med. 1969; 129(3):551-67. PMC: 2138617. DOI: 10.1084/jem.129.3.551. View

CURRIE G, Bagshawe K . Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase. Br J Cancer. 1969; 23(1):141-9. PMC: 2008319. DOI: 10.1038/bjc.1969.21. View

MATHE G, AMIEL J, SCHWARZENBERG L, Schneider M, Cattan A, SCHLUMBERGER J . Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969; 1(7597):697-9. DOI: 10.1016/s0140-6736(69)92648-8. View

MATHE G, Pouillart P, LAPEYRAQUE F . Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells. Br J Cancer. 1969; 23(4):814-24. PMC: 2008494. DOI: 10.1038/bjc.1969.101. View

Morton D, Eilber F, JOSEPH W, Wood W, Trahan E, KETCHAM A . Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg. 1970; 172(4):740-9. PMC: 1397284. DOI: 10.1097/00000658-197010000-00018. View

10.

Zbar B, Tanaka T . Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis. Science. 1971; 172(3980):271-3. DOI: 10.1126/science.172.3980.271. View

11.

Haywood G, McKHANN C . Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity. J Exp Med. 1971; 133(6):1171-87. PMC: 2138927. DOI: 10.1084/jem.133.6.1171. View

12.

Simmons R, Lipschultz M, Ray P . Failure of neuraminidase to unmask histocompatibility antigens on trophoblast. Nat New Biol. 1971; 231(21):111-2. DOI: 10.1038/newbio231111a0. View

13.

Simmons R, Rios A, Ray P . Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nat New Biol. 1971; 231(23):179-81. DOI: 10.1038/newbio231179a0. View

14.

Kassulke J, Stutman O, Yunis E . Blood-group isoantigens in leukemic cells: reversibility of isoantigenic changes by neuraminidase. J Natl Cancer Inst. 1971; 46(6):1201-8. View

15.

Simmons R, Rios A, Lundgren G, Ray P, McKHANN C, Haywood G . Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. Surgery. 1971; 70(1):38-46. View

16.

Schlesinger M, Amos B . Effect of neuraminidase on serological properties of murine lymphoid cells. Transplant Proc. 1971; 3(1):895-7. View

17.

Mitchison N . Immunologic approach to cancer. Transplant Proc. 1970; 2(1):92-103. View

18.

Ray P, Simmons R . Failure of neuraminidase to unmask allogeneic antigens on cell surfaces. Proc Soc Exp Biol Med. 1971; 138(2):600-4. DOI: 10.3181/00379727-138-35950. View

19.

Im H, Simmons R . Modification of graft-versus-host disease by neuraminidase treatment of donor cells. Decreased tolerogenicity of neuraminidase-treated cells. Transplantation. 1971; 12(6):472-8. DOI: 10.1097/00007890-197112000-00010. View

20.

Rios A, Simmons R . Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice. Cancer Res. 1972; 32(1):16-21. View